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Subunit rearrangement of the cyclin- 
dependent kinases is associated 
with cellular transformation 
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In normal human diploid fibroblasts, cyclins of the A, B, and D classes each associate with cyclin-dependent 
kinases (CDKs), proliferating cell nuclear antigen (PCNA), and p21, thereby forming multiple independent 
quaternary complexes. Upon transformation of diploid fibroblasts with the DNA tumor virus SV40, or its 
transforming tumor antigen (T), the cyclin D/p21/CDK/PCNA complexes are disrupted. In transformed cells, 
CDK4 totally dissociates from cyclin D, PCNA, and p21 and, instead, associates exclusively with a 
polypeptide of 16 kD (p16). Quaternary complexes containing cyclins A or B1 and p21/CDK/PCNA also 
undergo subunit rearrangement in transformed cells. Both PCNA and p21 are no longer associated with 
CDC2-cyclin B1 binary complexes. Cyclin A complexes no longer contain p21, and a new 19-kD polypeptide 
(p19) is found in association with cyclin A. The pattern of subunit rearrangement of cyclin-CDK complexes in 
SV40-transformed cells is also shared in those containing adeno- or papilloma viral oncoproteins. 
Rearrangement also occurs in p53-deficient cells derived from Li-Fraumeni patients that carry no known DNA 
tumor virus. These findings suggest a mechanism by which oncogenic proteins alter the cell cycle of 
transformed cells. 
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Neoplasia is characterized by deregulated cell growth 
and division. Inevitably, molecular pathways controlling 
cell growth must interact with those regulating cell di- 
vision. It was not until very recently, however, that ex- 
perimental evidence became available to bring such con- 
nection to light. Cyclin A was found in association with 
the adenovirus oncoprotein E1A in virally transformed 
cells (Giordano et al. 1989; Pines and Hunter 1990). In an 
early hepatocellular carcinoma, the human cyclin A 
gene was found to be the integration site of a fragment of 
the hepatitis B virus, which leads to activation of cyclin 
A transcription and a chimeric viral cyclin A protein that 
is not degradable in vitro (Wang et al. 1990, 1992). The 
cell cycle gene implicated most strongly in oncogenesis 
thus far is the human cyclin D1. It was originally iso- 
lated through genetic complementation f yeast G1 cy- 
clin deficiency (Lew et al. 1991; Xiong et al. 1991) as 
cellular genes whose transcription is stimulated by 
CSF-1 (colony-stimulating factor-l) in murine macro- 
phages (Matsushime t al. 1991) and as the putative on- 
cogene PRAD1 rearranged in parathyroid tumors (Mo- 
tokura et al. 1991). Two additional human D-type cy- 
clins, cyclin D2 and D3, were subsequently isolated 
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using PCR and low-stringency hybridization techniques 
(Inaba et al. 1992; Xiong et al. 1992a). Cyclin D1 is ge- 
netically linked to the bcl-1 oncogene, a locus activated 
by translocation to an immunoglobulin gene enhancer in 
some B-cell lymphomas and leukemias, and located at a 
site of gene amplification in 15-20% of human breast 
cancers and 25-48% of squamous cell cancers of head 
and neck origin (Withers et al. 1991, for review, see 
Hunter and Pines 1991; Lammie and Peters 1991). The 
biochemical role played by the cell cycle regulators in 
these tumors is not yet understood. 
Cyclins were originally discovered in invertebrate eggs 
as proteins whose abundance after fertilization oscillated 
during the early cleavage divisions owing to abrupt pro- 
teolytic degradation atmitosis (Rosenthal 1980; Evans et 
al. 1983; Swenson et al. 1986). Subsequently, cyclin 
genes have been isolated from virtually all eukaroytic 
species and constitute a multigene family (for review, 
see Xiong and Beach 1991). It is now well established 
that cyclins function by serving as regulatory subunits of 
the cdc2/CDC28 protein kinase (for review, see Draetta 
1990). In yeast cells, a single cdc2/CDC28 kinase con- 
trols both the G2/M and G1/S transitions through its 
association with different ypes of cyclins (Booher and 
Beach 1987; Wittenberg et al. 1990; Bueno et al. 1991; 
Ghiara et al. 1991; Surana et al. 1991). In vertebrates, 
however, cdc2 is a representative of a multi-gene family. 
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Through genetic complementation testing and identifi- 
cation of associated cyclin regulatory subunits, at least 
five cyclin-dependent kinases have been identified (Fang 
and Newport 1991; Paris et al. 1991; Tsai et al. 1991; 
Elledge et al. 1992; Matsushime t al. 1992; Meyerson et 
al. 1992; Pagano et al. 1992a, b; Rosenblatt et al. 1992; 
Xiong et al. 1992b). By use of PCR and low-stringency 
hybridization techniques, further potential members of 
the cdc2 family have been identified on the basis of their 
protein sequence similarities to cdc2 (Meyerson et al. 
1992; Okuda et al. 1992). Involvement of most of these 
protein kinases in cell cycle regulation, especially the 
possible association with cyclins, has yet to be estab- 
lished. 
To elucidate the mechanism by which the cyclin-de- 
pendent kinase (CDK) complexes control the cell cycle 
and cell growth, cellular p oteins that interact with cy- 
clin-CDK complexes must be identified. Cyclin A and 
CDK2 have been found to form a quaternary complex 
with a retinoblastoma gene product (Rb 1)-related protein 
(p107) and the transcription factor E2F in a cell cycle- 
regulated manner, suggesting that cyclin A-CDK2 ki- 
nase might be controlling ene expression during G1 and 
S phase of the cell cycle (Cao et al. 1992; Devoto et al. 
1992; Ewen et al. 1992; Faha et al. 1992; Pagano et al. 
1992b; Shirodkar et al. 1992; for review, see Nevins 
1992). Similarly, cyclin E was also found to form a qua- 
ternary complex with CDK2, p107, and E2F but in a tem- 
porally distinct manner from the cyclin A quaternary 
complex (Lees et al. 1992). D-type cyclins associate with 
multiple protein kinases and form quaternary complexes 
in normal human diploid fibroblast cells with proliferat- 
ing cell nuclear antigen (PCNA) and a polypeptide of 21 
kD, p21. Many combinatorial variations involving cyclin 
D1, D3, and CDK2, CDK4, and CDK5 may assemble in 
vivo (Xiong et al. 1992b). As reported elsewhere (H. 
Zhang, Y. Xiong, and D. Beach, in prep.), PCNA and p21 
serve as universal components of cyclin-CDK com- 
plexes. Here, we report that cellular transformation is
associated with selective subunit rearrangement of cy- 
clin-CDK complexes. 
Results 
Disruption of cyclin D/p21/CDK/PCNA complexes 
in SV40-transformed cells 
During attempts to identify cyclin D-associated catalytic 
subunits and other associated cellular proteins, we no- 
ticed that cyclin D/CDK/p21/PCNA quaternary com- 
plexes were detected in WI-38 and Hs68 cells, both of 
which are normal human diploid fibroblast cells, but 
such complexes were not detected in several other cell 
lines that are transformed (Xiong et al. 1992b). The ab- 
sence of the cyclin D quaternary complexes in these cells 
might be attributed to cell type specificity or to the con- 
sequence of cellular transformation. To directly test the 
latter possibility, we compared the subunit composition 
of cyclin D complexes in normal human diploid fibro- 
blasts and their transformed erivatives. WI-38 VA13, 
subline 2RA (hereafter referred to as VA13), is an SV40 
virus-transformed derivative of the WI-38 cell line (see 
Materials and methods). Expression of SV40-encoded 
large T antigen in VA13 cells, in addition to other SV40- 
transformed cells used in this study (see below), has been 
confirmed by immunoblotting (data not shown). Anti- 
cyclin D1 immunoprecipitates of [3SS]methionine-la- 
beled WI-38 and VA13 lysates were examined. As shown 
previously in WI-38 cells, the anti-cyclin D1 antiserum 
precipitates a dominant 35-kD band corresponding to cy- 
din D1 and three major associated proteins, p36 PCNA, 
p33 CDK4, and p21 (Fig. 1, lane 10, note that the molecular 
identity of these proteins has been formally confirmed in 
Xiong et al. 1992b). In SV40-transformed VA13 cells, the 
level of cyclin D1 is decreased by two- to threefold as 
determined by autoradiography of [3S]methionine-la- 
beled immunoprecipitates (Fig. 1, lanes 10,11), and by 
Western blotting (data not shown). Strikingly, none of 
the three major cyclin Dl-associated proteins was visi- 
bly associated with cyclin D 1 in SV40-transformed VA13 
cells. Reciprocal immunoprecipitations were carried out 
with anti-CDK4 and anti-CDK2 antisera to confirm the 
observed disruption of cyclin D complexes in SV40- 
transformed cells. In WI-38 cells, anti-CDK4 antibody 
precipitated CDK4 in addition to three major associated 
proteins, p36 PCNA, p35 cyclin D1, and p21 (Xiong et al. 
1992b; Fig. 1, lane 6). The specificity of these associa- 
tions has been established previously and was confirmed 
further here by peptide competition (Fig. 1, lane 7). In 
SV40-transformed VA13 cells, whereas CDK4 is present 
at a similar level compared with untransformed WI-38 
cells (cf. lanes 6 and 8 of Fig. 1 with lanes 3 and 4 of Fig. 
3A, below), no detectable PCNA, cyclin D1, or p21 was 
present in the anti-CDK4 immunoprecipitates (Fig. 1, 
lane 8). Similar results were also observed in immuno- 
precipitates with anti-CDK2, another cyclin D-associ- 
ated kinase catalytic subunit. Cyclin D1 is one of the 
major CDK2-associated proteins in WI-38 cells (Xiong et 
al. 1992b; Fig. 1, lane 3), but the association is undetect- 
able in SV40-transformed VA13 cells, even though the 
level of CDK2 is similar or slightly higher in the trans- 
formed cells (Fig. 1, lane 5). Also, the level of CDK2- 
associated p21 was reduced in transformed cells but is 
present at a detectable l vel (Fig. 1, lanes 4,5). As shown 
below, the p21 present in anti-cdk2 precipitates probably 
consists of p21 present in p21/cyclin A/CDK2 com- 
plexes. As reported recently (Zhang et al. 1993), CDC2 
associates with cyclin D1, although at a much lower 
level compared with CDK4 and CDK2. The association 
between cyclin D1 and CDC2 also declines to undetect- 
able levels in SV40-transformed VA13 cells (Fig. 1, lanes 
1,2; note that the molecular identity of PCNA, cyclin 
D1, and p21 in CDC2 complexes is formally demon- 
strated in H. Zhang, Y. Xiong, and D. Beach, in prep.). 
Reciprocal experiments examining anti-PCNA and anti- 
p21 immunoprecipitates were not performed because of 
the lack of suitable immunological reagents that can pre- 
cipitate PCNA-cyclin D complexes and the unknown 
molecular identity of p21 at the present ime. 
To seek further evidence concerning the subunit corn- 
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Figure 1. [3S]Methionine-labeled immunoprecipitates of normal and transformed fibroblasts. [3S]Methionine-labeled immunoprecip- 
itates were prepared from normal human diploid fibroblast WI-38 cells (lanes 1,4,5, 7,8,11,13) and SV40-transformed VA13 cells (lanes 
2,6,9,10,12,14) asindicated by SV40 - or + at the top of each lane. Conditions for immunoprecipitations a d electrophoresis are 
described in Materials and methods. Proteins in each immunoprecipitate whose identity has been established are marked at left, and 
molecular mass markers are indicated at right. Molecular masss markers next to lanes 11 and 12 also apply to lanes I-10. The presence 
and absence of c mpeting peptide in anti-CDK2 and anti-CDK4 immunoprecipitations are indicated by + and - ,  respectively, at the 
top of each lane. 
position of cyclin D complexes in transformed cells, sev- 
eral additional normal human diploid fibroblast cell 
lines and their SV40-transformed derivatives were exam- 
ined. HSF43, a diploid fibroblast cell line derived from 
neonatal foreskin and CT10-2C-T1 (hereafter referred to 
as CT10), was obtained from HSF43 by introduction of a 
plasmid containing the SV40 large tumor antigen gene 
(T) driven by a Rous sarcoma virus (RSV) promoter (Ray 
et al. 1990). The pattern of subunit composition and dis- 
sociation of the normal and transformed cells was very 
similar to that observed in the WI-38 and VA13 cells. No 
cyclin D1 was seen in anti-CDK4 (Fig. 2, lane 6), anti- 
CDK2 (lane 4), and anti-CDC2 (lane 2) immunoprecipi- 
tates prepared from T-transformed CT 10 cells, but it was 
apparent in the HSF43 cells. {Fig. 2, lanes 1,3,5). Recip- 
rocally, CDK4 was not seen in anti-cyclin D1 precipi- 
tates in CT10 cells (data not shown). CDK4-associated 
PCNA and p21 were also not detected in CT10 cells (Fig. 
2, lane 6). p21 in the T-transformed cells appeared to be 
replaced by a newly identified p16 protein (Fig. 2, lane 6) 
as in the VA13 cell line (Fig. 1, lane 8). In addition, es- 
sentially identical results were also obtained from other 
pairs of human fibroblast cell lines, IMR-90, a normal 
human lung diploid fibroblast cell line and its T-trans- 
formed derivative IDH4 (Shay et al. 1992), as well as a 
pair of monkey cell lines, CV-1, a pseudodiploid kidney 
cell line, and its SV40-transformed derivative COS-1 
(Gluzman 1981; data not shown). 
To further confirm the observed issociation of cyclin 
D complexes in transformed cells, immunoprecipitation 
coupled with immunoblotting experiments, was per- 
formed to avoid potential artifacts that can arise in met- 
abolic labeling experiments. Total lysates prepared from 
either untransformed WI-38 or SV40-transformed VA13 
cells were immunoprecipitated with a battery of anti- 
bodies, separated electrophoretically, and blotted with 
various secondary antibodies. CDK4 (Fig. 3A, lanes 1,2), 
CDK2 (data not shown), and PCNA (Fig. 3C, lanes 13,14) 
were either not detected (CDK4) or were present at dra- 
matically decreased levels (CDK2 and PCNA) in anti- 
cyclin D1 precipitates derived from SV40-transformed 
cells. In each case, direct immunoblotting confirmed 
that the absolute level of CDK4 (Fig. 3A, lanes 3,4), 
CDK2 (data not shown), and PCNA (Fig. 3C, lanes 17,18) 
is similar in normal and transformed cells. Reciprocally, 
cyclin D1 was not detected in either anti-CDK2 (Fig. 3B, 
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Figure 2. [3S]Methionine-labeled immunoprecipitates of normal HSF43 and SV40 large tumor antigen-transformed CT10 cells. Con- 
ditions for immunoprecipitations a d electrophoresis, and markers for protein identities and molecular mass are the same as described 
in the legend to Fig. 1, except a different pair of cell lines was used. HSF43 is a diploid fibroblast cell line derived from neonatal 
foreskin, and CT10-2C-T1 (CT10) cell line was derived from nontransformed HSF43 by the introduction of a plasmid containing the 
gene for SV40 large tumor antigen (T) linked to a RSV promoter (Ray et al. 1990). 
lane 2) or anti-CDK4 precipitates derived from trans- 
formed VA13 cells (Fig. 3B, lane 5) The same results 
were also obtained from the other pair of cell lines, 
HSF43 and CTIO (Fig. 3, A-C). 
Subunit rearrangement of cyclin A and B complexes 
in transformed cells 
As reported recently, PCNA and p21 not only associate 
with cyclin D-CDK to form a quaternary complex as 
described previously (Xiong et al. 1992b), but also are 
present as universal components of cyclin-dependent ki-
nases in all normal human diploid fibroblast cells that 
we have examined (H. Zhang, Y. Xiong, and D. Beach, in 
prep.). Thus, we went further to examine the subunit 
composition of cyclin A complexes in untransformed 
WI-38 cells and SV40-transformed VA13 cells. Cyclin A 
associates with p36 PCNA, p33 CDC2, p33 CDK2, and p21 in 
WI-38 cells (H. Zhang, Y. Xiong, and D. Beach, in prep.; 
Fig. 1, lane 12). In SV40-transformed VA13 cells, the 
level of both cyclin A itself and cyclin A-associated 
CDC2/CDK2 increased approximately threefold (Fig. 1, 
lane 13). Reciprocally, the level of CDC2- and CDK2- 
associated cyclin A is also increased two- to threefold 
(Fig. 1, lanes 1,2 and lanes 3,5, respectively). The in- 
creased abundance and association of cyclin A and 
CDC2/CDK2 in transformed cells was also confirmed in 
immunoblotting coupled with immunoprecipitation ex- 
periments (data not shown). 
The level of cyclin A-associated PCNA is reduced in 
immunoprecipitates of [3s] methionine-labeled VA13 
cell lysates, compared with WI-38 cell lysates (Fig. 1, 
lanes 12,13). As determined by immunoblotting, how- 
ever, the level of cyclin A-associated PCNA in trans- 
formed VA13 cells is higher than that in untransformed 
WI-38 cells (Fig. 3C, lanes 5,6). Also, the level of CDK2- 
associated PCNA is higher in VA13 cells compared with 
WI-38 cells (Fig. 3C, lanes 1,2). Using a different pair of 
fibroblast cell lines, essentially the same results were 
obtained. The level of CDC2-, CDK2-, and cyclin A-as- 
sociated PCNA is lower in SV40 large tumor antigen- 
transformed CT10 cells than that in untransformed dip- 
loid HSF43 cells, as measured in immunoprecipitates of 
[3s] methionine-labeled cell lysates (Fig. 2, lanes 
1,2,3,4,7,8). As determined by immunoblotting coupled 
with immunoprecipitation, however, the opposite result 
is obtained (Fig. 3C, lanes 3,4,7,8). A possible explana- 
tion for this experimental discrepancy is that more pre- 
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Figure 3. Immunoblotting analysis of cyclin-CDK complexes in normal and transformed cells. (A) Cell lysates prepared from normal 
WI-38 and HSF43 cells (indicated by SV40 -) or transformed VA13 and CT10 cells (+) were immunoprecipitated by a variety of 
antisera s indicated at the top of each lane. Following SDS-PAGE, the blot was probed with anti-CDK4 serum. Lane 5 is the same as 
lane 4, except a competing CDK4 peptide was included in the immunoprecipitation. (B) Cell lysates prepared from normal WI-38 and 
HSF43 cells (indicated by SV40 -) or transformed VA13 and CT10 cells (+) were immunoprecipitated by a variety of antisera s 
indicated at the top of each lane. Following SDS-PAGE, the blot was probed with anti-cyclin D1 serum. Lane 4 is the same as lane 3, 
except a competing CDK4 peptide was included in the immunoprecipitation. (C) Cell lysates prepared from normal WI-38 and HSF43 
cells (indicated by SV40 - ) or transformed VA13 and CT10 cells (+) were immunoprecipitated by a variety of antisera s indicated 
at the top of each lane, xcept lanes 17-20, where total cell lysates from different cells were loaded directly onto he SDS gel without 
prior immunoprecipitation. Following SDS-PAGE, the blot was probed with anti-PCNA serum. 
existing PCNA, rather than newly synthesized PCNA, 
associates with cyclin-CDK in transformed cells rather 
than normal cells. This observation suggests that both 
metabolic labeling and immunoprecipitation coupled 
with immunoblotting should be used to assess the status 
of any given molecular interaction. An approximate s- 
timation of the stoichiometry of the cyclin/CDK/ 
PCNA/p21 interaction is given in H. Zhang, Y. Xiong, 
and D. Beach (in prep.). 
With regard to the association of p21 with members of 
the cyclin A/CDK family only metabolic labeling can 
presently be used. The level of cyclin A-associated p21, 
as determined by immunoprecipitation of [3S]methio- 
nine-labeled cell lysates, is rcduced in VA13 cells as 
compared with WI-38 cells (Fig. 1, lanes 12,13). A low 
level of p21 is also present in the immunoprecipitates 
prepared from VA13 cells using antisera against CDK2, 
the major catalytic partner of cyclin A (Fig. 1, lane 5). 
Consistently, the same results were obtained using 
HSF43 and CT10 cells (Fig. 2, lanes 7,8), in addition to 
normal IMR-90 cells versus their T-transformed IDH4 
cells, and monkey CV-1/COS-1 pair cell lines (data not 
shown). The lack of immunological reagents for p21 pre- 
vented us from determining whether the decrease of cy- 
clin A-, and CDK2-associated p21 is attributable to lower 
abundance or slower synthesis in transformed cells. 
A number of other polypeptides were noticed in cyclin 
A precipitates that are specific to untransformed cells or 
to transformed cells. For example, a protein with a mo- 
lecular mass of 42 kD is seen as a predominant band in 
untransformed WI-38 or HSF43 cells but not in trans- 
formed VA13 or CT10 cells (Fig. 1, lanes 12,13; Fig. 2, 
lanes 7,8). Conversely, a polypeptide of 95 kD, which 
might correspond to the T antigen, is seen only in trans- 
formed cells. 
We have also examined the subunit composition of 
cyclin B1 complexes in normal and transformed cells. In 
common with cyclin D1, the quaternary complex of cy- 
clin B1/CDK/p21/PCNA is altered in both SV40-trans- 
formed VA13 cells and T-transformed CT10 cells as 
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compared with nontransformed WI-38 and HSF43 cells 
(Fig. 4, lanes 1--4). Thus, neither PCNA nor p21 associ- 
ates with cyclin B/CDK in the transformed cells. As re- 
ported previously (Draetta and Beach 1988), however, 
CDC2 is associated with cyclin B1 (p62) in VA13, CT10, 
293, and HeLa cells (Fig. 4). 
Cyclin and CDK complexes in other DNA tumor virus- 
transformed cells 
To investigate whether cyclin-CDK complexes are also 
altered in other human tumor cells, papilloma virus-con- 
taining cervix carcinoma HeLa cells and adenovirus- 
transformed primary kidney 293 cells were examined for 
the subunit composition of various cyclin and CDK 
complexes. Both of these cell lines have been used 
widely in biochemical studies of the mammalian cell 
Figure 4. Analysis of [aS]methionine-labeled a-cyclin B1 im- 
munoprecipitates. Subunit composition ofcyclin B1 complexes 
was examined in normal WI38 (lane 1) and HSF43 (lane 3) fi- 
broblasts, SV40-transformed VA13 (lane 2) and CT10 (lane 4)
cells, and two ther DNA tumor virus-transformed cells, HeLa 
(papilloma virus, lane 5) and 293 (adenovirus, lane 6). [3S]Methi- 
onine-labeled lysates prepared from each cell line were immu- 
noprecipitated byan ~-cyclin B 1 serum and electrophoretically 
separated on a 15% SDS-polyacrylamide g l as described in 
Materials and methods. Proteins whose identities have been 
established are marked at left, and the positions of molecular 
size markers are indicated at right. 
Cell cycle and cellular transformation 
cycle (see Draetta and Beach 1988). Cyclin D1 is ex- 
pressed at a low level in HeLa cells and is barely detect- 
able in 293 cells (Fig. 5, lanes 11,12). The subunit com- 
position of other cyclin/CDK complexes, however, can 
be investigated. 
The well-established association of CDC2-cyclin B1, 
CDC2-cyclin A, and CDK2-cyclin A were all readily 
detected in both HeLa and 293 cells (Fig. 4, lanes 5,6; Fig. 
5, lanes 1,2,3,4,9,10). No p21 was seen, however, in anti- 
CDC2 (Fig. 5, lanes 1,2), anti-CDK2 (Fig. 5, lanes 3,4), 
anti-cyclin A (Fig. 5, lanes 9,10), or anti-cyclin B1 (Fig. 4, 
lanes 5,6) immunoprecipitates from either HeLa or 293 
cells. Thus, the quaternary complexes of cyclin A/CDK/ 
p21/PCNA and cyclin B1/CDK/p21/PCNA are either 
not assembled or are present at extremely low levels in 
these DNA tumor virus-transformed cells. Interestingly, 
a new cyclin A complex appeared, in which p21 seems to 
be replaced by a polypeptide of 19 kD (p19, Fig. 5, lanes 
9,10). The specificity of the cyclin A-pl9 association and 
the potential significance of this new complex is unclear, 
but a similar 19 kD polypeptide is present in anti-cyclin 
A precipitates from SV40-transformed human VA13 (Fig. 
1, lane 13), CT10 (Fig. 2, lane 8), IDH4 (data not shown), 
and even monkey COS-1 cells (data not shown). Further- 
more, in 293 and HeLa cells, the subunit composition of 
CDK4 is identical to that of the T-antigen-transformed 
cells. Cyclin D1 is not associated with CDK4 (trivially 
attributable to absence of cyclin D from the cell), but 
PCNA and p21 are also absent, p21 has been replaced by 
p16 in HeLa and 293 cells. In a much longer exposure of 
Figures 1 and 2, we have also seen CDK4-associated p16 
in untransformed WI-38 or HSF43 cells. Proteolytic 
cleavage mapping in each case reveals that the CDK4- 
associated p16 from HeLa, 293, VA13 and WI-38 cells is 
identical, but different from p21 (Fig. 6). Presence of p19 
and p16 in cells transformed by three different viruses 
and p16 in untransformed cells indicates that they are 
not virally encoded proteins. The molecular identities of 
p21, p 19, and p 16 are currently unknown. 
Alteration of cyclin and CDK complexes in Li- 
Fraumeni cells 
Alteration of subunit composition of CDKs in cells 
transformed by three different DNA tumor viruses pro- 
voked us to ask further whether cyclin-CDK complexes 
are also altered in nonvirally transformed cells. Unlike 
mouse cells, which can be readily transformed by a var- 
ious oncogenes, it is exceedingly difficult to experimen- 
tally transform or induce the immortalization of normal 
hurhan cells by chemicals, physical methods, or onco- 
genes other than DNA tumor viruses (for review, see 
McCormick et al. 1988; Shay et al. 1991). Fibroblasts 
from familial Li-Fraumeni patients, however, exhibit an 
elevated rate of spontaneous abnormalities, including 
aneuploidy and immortalization (Li and Fraumeni 1969; 
Bischoff et al. 1990). These cells do not contain any 
known viruses; instead, single-base heterozygous muta- 
tions of the tumor suppressor gene p53 are the only re- 
ported germ-line alteration (Malkin et al. 1990; Srivas- 
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Figure 5. Analysis of [3S]methionine-labeled immunoprecipitates of HeLa and 293 cells. Subunit composition ofa variety of cell cycle 
complexes was examined further in two different DNA tumor virus-transformed cells, HeLa (papilloma virus) and 293 (adenovirus). 
[3s] Methionine-labeled ysates prepared from either cell line were immunoprecipitated by avariety of antisera s indicated at the top 
of each lane. Conditions for immunoprecipitations a d electrophoresis are described in Materials and methods. Proteins in each 
immunoprecipitate whose identities have been established are marked at left of each panel. 
tava et al. 1990). Escape from senescence and spontane- 
ous immortal ization of Li-Fraumeni fibroblasts during 
continued passage in vitro is associated with secondary 
loss of the wild-type p53 allele (Yin et al. 1992}. [3S]Me- 
thionine-labeled cell lysates from a spontaneously im- 
mortalized Li-Fraumeni cell line, LCS041 (previously 
MDAH041; Little et al. 1987; Bischoff et al. 1990, pas- 
sage >170) were immunoprecipitated with a variety of 
antibodies and analyzed by SDS-PAGE. The level of 
most of these proteins in LCS041 cells is similar to that 
in normal diploid fibroblasts, as determined by meta- 
bolic labeling and immunoblotting, except hat cyclin A 
is expressed at a much lower level compared with nor- 
mal fibroblasts (data not shown). The subunit composi- 
tion of cyclin and CDK complexes i grossly abnormal in 
LCS041 cells (Fig. 7A). Cyclin B1-CDC2 complexes exist 
as in HeLa and 293 cells and are not associated with p21 
or PCNA (Fig. 7A, lanes 1,7). The cyclin D1-CDK4 as- 
sociation is reduced to a barely detectable level in
LCS041 cells, and both PCNA and p21 are absent (Fig. 
Figure 6. Partial V8 proteolytic mapping 
of CDK4-associated p16. p16 polypeptides 
coprecipitated with CDK4 were purified 
from WI-38 (lanes 7-9), VA13 (lanes 10- 
12), HeLa (lanes 13-15), and 293 cells 
(lanes 16-18}. They were analyzed by a par- 
tial V8 protease digestion, as described in 
Materials and methods, and compared 
with p21 purified from anti-cyclin D1 
(lanes 1-3) or anti-CDK4 immunoprecipi- 
tates (lanes 4-6) derived from WI-38 ceils. 
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Figure 7. Analysis of cyclin and CDK complexes in Li-Fraumeni 
cells. (A) [35] Methionine-labeled cell lysates prepared from 
LCS041 cells of a Li-Fraumeni patient (lanes 1-8) and normal 
human diploid fibroblast WI-38 cells (lane 9) w re immunopre- 
cipitated with a variety of antisera s indicated at the top of each 
lane. Conditions for immunoprecipitations, peptide competition, 
and electrophoresis are described in Materials and methods. Pro- 
teins in the a-cyclin B 1 immunoprecipitate of normal WI-38 cell 
lysate whose identities have been established are marked at right; 
the positions of molecular size markers are indicated at left. Pres- 
ence and absence of competing peptide in anti-CDK2 and anti- 
CDK4 immunoprecipitations were indicated by + and - ,  respec- 
tively, at the top of each lane. {B) Equal amounts of cell lysates 
prepared from LCS041 cells of a Li-Fraumeni patient were im- 
munoprecipitated by a variety of antisera s indicated at the top 
of each lane. Lane 7 is an a-cyclin D1 immunoprecipitate pre- 
pared from normal diploid HSF43 fibroblasts. (Lanes 8,9) Total 
cell lysates from either LCS041 or HSF43 cells were loaded di- 
rectly on to the SDS gel without prior immunoprecipitation. Fol- 
lowing SDS-PAGE, the blot was probed with anti-PCNA serum. The bands seen i lanes 1-6 correspond to the IgG heavy chain, and 
all lanes were from the same gel. 
7A, lanes 4,8}. p21 was not detected in any of the cyclin- 
CDK complexes investigated in LCS041 cells and was 
not replaced by p16 or p19 proteins as occurs in T-anti- 
gen-transformed fibroblasts (Fig. 7A). The level of PCNA 
associated with cyclin-CDK complexes is also dramati- 
cally reduced in every case. Direct immunoblotting dem- 
onstrated that the abundance of PCNA is higher in 
LCS041 cells, compared with normal fibroblasts (Fig. 7B, 
lanes 8,9), but PCNA is dramatically reduced or entirely 
absent from immunocomplexes i olated with anti- 
CDC2, CDK2, CDK4, cyclin A, cyclin B1, and cyclin D1 
(Fig. 7B, lanes 1-6). Essentially identical results were 
also obtained by use of another Li-Fraumeni cell line, 
LCS087 (previously MADH087), obtained from a differ- 
ent patient (data not shown). 
Discussion 
The observations in this paper provide striking evidence 
that the cyclin/CDK family of enzymes that act at mul- 
tiple key steps in the cell division cycle are grossly al- 
tered in a variety of oncogenically transformed ceils. To 
date, we have only used so-called normal diploid fibro- 
blasts as a model for untransformed cells. In a wide va- 
riety of fibroblasts, from different sources, each member 
of the cyclin/CDK family that we have investigated (cy- 
clin E was not studied because of its relatively low abun- 
dance in fibroblasts) associated, to some extent, with 
PCNA and p21. Cell transformation by T antigen is ac- 
companied by apparent total dissolution of p21, PCNA, 
and CDK4 and substantial dissociation of CDK2 from 
cyclin D. This pattern is partially shared by the cyclin 
B-CDC2, CDK2 enzyme. Both p21 and PCNA dissoci- 
ated, but as described originally (Draetta and Beach 
1989}, the core enzyme is present in transformed cells. 
The pattern of behavior of the cyclin A-CDC2, CDK2 
enzyme is quite different. The abundance of the cyclin- 
CDK complex increases, as does the association with 
PCNA. In many of the cell cycle kinase complexes p21 is 
not simply altered in its relative stoichiometry in trans- 
formed cells, but it is replaced by a different polypeptide 
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of a slightly different apparent molecular mass (p16 and 
p19). The possibility of any of these proteins bearing any 
relationship to the cdc2-associated p l3SUcl/CKS (Brizu- 
ela et al. 1987; Draetta et al. 1987; Richardson et al. 
1990) awaits molecular cloning of p21, p19, and p16. 
The pattern of subunit alteration in fibroblasts trans- 
formed by T antigen is not restricted to this particular 
oncoprotein. Human cervix carcinoma HeLa cells (pap- 
illoma transformed) and 293 cells (adenovirus-trans- 
formed) carry different DNA tumor viral oncoproteins, 
in addition to a mass of other oncogenic lesions. Both, 
however, broadly share T-antigen-associated patterns of 
subunit composition of the cell cycle kinases, with the 
exception of cyclin D, which is present at a very low 
level in these cell types. Furthermore, subunit alteration 
of CDK complexes was also found in several other hu- 
man tumor cell lines that we have examined, including 
epidermoid carcinoma A-431, pharynx squamous cell 
carcinoma FaDu, and breast adenocarcinoma MCF7. No 
quaternary CDK complex was detected for any cyclins or 
CDKs in these lines (Y. Xiong and D. Beach, unpubl.). 
From these experiments and the studies on Li-Fraumeni 
cells, as discussed below, we suggest hat subunit rear- 
rangement of the cyclin-dependent kinases is associated 
with cellular transformation i general. 
It is well established that DNA tumor antigens can 
interact with components of the cell cycle regulatory 
apparatus (Giordano et al. 1989, 1991; Tsai et al. 1991; 
Ewen et al. 1992; Faha et al. 1992). Thus, we were par- 
ticularly interested in the study of fibroblasts that are 
transformed by means other than DNA tumor viruses. 
Fibroblasts derived from Li-Fraumeni patients present 
an ideal opportunity. These fibroblasts are initially het- 
erozygous with regard to mutations in the p53 tumor 
suppressor gene. During passage in culture, the wild-type 
allele of p53 becomes mutant and the cells display cer- 
tain characterization of morphological transformation 
(Bischoff et al. 1990; Yin et al. 1992). We found that the 
pattern of subunit composition of the cyclin kinase fam- 
ily was grossly abnormal in Li-Fraumeni fibroblasts. The 
pattern partially resembled that of T-antigen-trans- 
formed cells, but p21 was apparently not replaced by 
either p19 or p16 in any of the cell cycle kinase com- 
plexes. These results strongly suggest that the alteration 
of cyclin/CDK enzymes in transformed cells is not sim- 
ply attributable to direct or indirect binding of a DNA 
tumor viral oncoprotein to one or more individual sub- 
units of the cyclin-CDK complexes. All three DNA tu- 
mor viruses are believed to share a common mechanism 
in cellular immortalization and transformation. Each en- 
codes an oncoprotein, T antigen of SV40, E6 of papilloma 
virus, and E1B of adenovirus, which can bind to and pre- 
sumbly inactivate the function of the p53 protein. From 
these observations and our studies on Li-Fraumeni cells, 
we suggest hat the p53 regulates the cyclin-CDK com- 
plexes in normal cells and loss of the p53 function in 
tumor cells may contribute to the alteration of these 
9 complexes. We believe that the striking observations in 
this paper were not noticed previously because, since the 
original biochemical analysis of cdc2 in human HeLa 
cells {Draetta nd Beach 1988), investigators have over- 
whelmingly used transformed cells for cell cycle studies. 
The findings in this study raise a large number of ques- 
tions. Alone among the known elements of the cell cycle 
kinases, cyclin D 1 has been directly implicated in onco- 
genesis as PRAD1 and bcI-1 oncogene (Motokura et al. 
1991; Withers et al. 1991) and as a candidate oncogene at 
the 1 lq13 locus that is amplified in a variety of clinical 
conditions. Since the discovery that cyclins A and B di- 
rectly interact with cdc2 (Draetta et al. 1989}, it has be- 
come increasingly apparent that cyclins act by virtue of 
their association with a CDC or CDK catalytic subunit. 
Cyclin D1 associates with CDC2, CDK2, CDK4, and 
CDK5 (Matsushime t al. 1992; Xiong et al. 1992b; 
Zhang et al. 1993). Thus, the original hypothesis regard- 
ing the molecular function of cyclins (Draetta et al. 1989) 
has not been violated. In T-antigen-transformed fibro- 
blasts, however, association of cyclin D 1 with CDK4 and 
CDC2 is totally disrupted and cyclin D 1 and CDK2 as- 
sociation is substantially reduced (this study). It has been 
shown recently {Baldin et al. 1993) that cyclin D1 is es- 
sential for the G1/S-phase transition in normal fibro- 
blasts, and it will be of interest o know whether this is 
also the case in transformed fibroblasts. 
In this context, it has been demonstrated that cyclin D 
can bind directly to the retinoblastoma (Rb) anti-onco- 
protein in vitro (Matsushime t al. 1992; Hall et al. 1993; 
Kato et al. 1993). Addition of a CDK4 catalytic subunit 
results in phosphorylation of Rb and dissociation of the 
Rb-cyclin D complex (Kato et al. 1993). Phosphorylation 
of Rb is thought o negate its growth- suppressive ffect 
(Buchkovich et al. 1989; DeCaprio et al. 1989; Ludlow et 
al. 1990). It is quite possible that cyclin D might inhibit 
Rb function (and/or that of related proteins) not only by 
phosphorylation but also by direct Rb-cyclin D associa- 
tion, in the absence of catalytic function, thus creating a
substrate trap. We would emphasize that although cyclin 
D1 apparently dissociates totally from CDKs in T-anti- 
gen-transformed cells, this particular effect is less appar- 
ent in certain other tumor cell lines such as A431 or 
MCF7, which express high levels of cyclin D1. 
A further question raised by other studies concerns the 
role of PCNA. The function of PCNA in DNA replica- 
tion and repair is well established by biochemical exper- 
iments (Prelich et al. 1987a, 1987b; Prelich and Stillman 
1988; Toschi and Bravo 1988; Shiviji et al. 1992). We 
now find PCNA in the mitotic cyclin B-CDC2 com- 
plexes of normal cells, however, but not in any trans- 
formed cells that we have investigated. The function of 
PCNA in the cell cycle kinase complexes is unknown at 
present, but we suggest that this protein has a far broader 
function than has been suspected previously. For exam- 
ple, the PCNA (and p21) that is associated with cyclin- 
CDK complexes may function as a sensor for detecting 
DNA damage, growth conditions, or other signals. 
A variety of lines of evidence suggest hat the associ- 
ation between cyclins and their catalytic partners is not 
entirely passive. In particular, phosphorylation of the 
threonine residue 161 of cdc2 (or its equivalent in CDK2) 
by a protein kinase termed cdc2-activating kinase (CAK) 
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is required for full binding of cycl in/CDK (Ducommun 
et al. 1991). Cyclin A, and recently cyclin D1 as well, 
were found to be phosphorylated on tyrosine residues in 
vivo (Hall et al. 1991; 1993). We do not know whether 
the cyclin kinase subunit rearrangements that we have 
observed in this study reflect altered activity of CAK or 
phosphatases that might act on an individual subunit of 
cycl in-GDK complexes; however, these are attractive 
possibilities that can be investigated. 
A final key question concerns the biochemical and 
physiological consequences of the observations de- 
scribed here. For many years, there has been debate 
about the relative nature of the cell division cycle of the 
normal and cancer cell. In very general terms, it has been 
concluded that both normal and cancer cells of any given 
type have roughly similar G1, S, G2, and M phases, and 
that the difference between ormal and tumor tissue lies 
instead in the growth fraction, or the percentage of cells 
that are proliferatively active in any given situation. 
This finding has tended to focus attention on growth 
factors, their receptors, and signal transduction path- 
ways that regulate the growth fraction. We would point 
out, however, that an altered response to a given physi- 
ological milieu might be obtained just as readily by al- 
teration of the underlying cell cycle regulatory machin- 
ery (cyclins, CDK, etc.), as by alteration of the signal 
transduction pathways themselves. This study suggests 
that abnormality of signal transduction and cell cycle 
pathways are likely to be equally involved in oncogene- 
sis. 
Materials and methods 
Cell culture 
Human diploid lung fibroblast WI-38 cells were obtained from 
the American Type Culture Collection (ATCC, CCL75) at pas- 
sage 13 and used between passages 16 and 25. VA13, subline 
2RA (ATCC CCL 75.1), is an SV40 virus-transformed derivative 
of the WI-38 cell line and was obtained from ATCC. HSF43 is a 
human diploid fibroblast strain derived from neonatal foreskin, 
and CT10-2C-T1 (CT10) was derived from nontransformed 
HSF43 by introduction of a plasmid containing the SV40 virus 
large tumor antigen (T) gene linked to a RSV promoter (Ray et 
al. 1990). Both HSF43 and CT10 cell lines were kindly provided 
by Dr. F. Andrew Ray (Los Alamos National Laboratory, NM). 
CV-1 is an African green monkey kidney cell line, and COS-1 is 
a SV40 virus-transformed derivative of CV-1 cell line. HeLa is a 
human cervix epitheloid carcinoma cell line, and 293 is an ad- 
enovirus-transformed human embryonal kidney cell line. 
LCS041 (previously MDAH041) and LCS087 (previously 
MADH087) fibroblasts were isolated from skin biopsies of two 
patients with Li-Fraumeni syndrome as described previously 
[Little et al. 1987; Bischoff et al. 1990; kindly provided by Dr. S. 
Friend (Massachusetts General Hospital, Boston) and M. Tain- 
sky (M.D. Anderson Cancer Center of The University of Texas)] 
and were used between passages 170 and 175 and 70 and 75, 
respectively. All cells were grown in Dulbecco's modified Eagle 
medium (DMEM) supplemented with 10% fetal bovine serum 
fiBS) in a 37~ incubator with 5% CO2, except HeLa and 293, 
which were cultured in DMEM supplemented with 5% calf 
serum.  
Antibodies and immunological methods 
Antisera against human cyclin D1 (Xiong et al. 1992b), human 
cyclin A (Pagano et al. 1992b), and human CDC2 (G6, Draetta 
and Beach 1988) have been described previously. Anti-human 
CDK2 peptide antibody was raised against a synthetic peptide 
corresponding to the carboxy-terminal region of human CDK2 
(K. Galaktionov, unpubl.). Anti-human CDK4 peptide antibody 
was raised against a synthetic peptide CHSYLHKDEGNPE~ 
with the underlined region corresponding to the carboxy-termi- 
nal region of human CDK4 (H. Zhang, Y. Xiong, and D. Beach, 
in prep.). Affinity-purified anti-PCNA monoclonal antibody 
was purchased from Oncogene Science, Inc. {Uniondale, NY). 
Immunoprecipitation and Western blotting procedures were es- 
sentially the same as described previously with a modification 
only in the NP-40 lysis buffer (50 mM Tris-HC1 at pH7.4, 150 
mM NaC1, 0.5% NP-40, 50 mM NaF, 1 mM Na3VO4, 1 mM DTT, 
1 mM PMSF, 25 ~g/ml of leupeptin, 25 ~g/ml of aprotitin, 1 mM 
benzamidine, 10 ~g/ml of trypsin inhibitor). For the peptide 
competition experiments, 1 ~g of synthetic peptides was prein- 
cubated with 1 ~1 of specific antisera before the immunoprecip- 
itation. 
Partial proteolytic peptide mapping 
Immunoprecipitation of [3S]methionine-labeled lysates and 
SDS-PAGE were the same as described above. Polyacrylamide 
gels were dried without prior fixation and enhancer treatment, 
exposed to Fuji image plates, and visualized on Fuji Bio-imaging 
Analyzer BAS2000. Appropriate protein bands were excised 
from the gels, with the image printout as template, partially 
digested in the gel with various amount of Staphylococcus au- 
reus V8 protease according to Cleveland et al. (1977) and Harlow 
and Lane (1988), separated on a 17.5% SDS-PAGE. Gels were 
analyzed on Fuji image analyzer BAS2000. 
Acknowledgment  
We particularly thank Dr. Giulio Draetta for providing anti- 
cyclin A and anti-CDK2 antisera, Dr. Steven Hanks for anti- 
CDK4 (PSK-13) antiserum, Dr. Konstantin Galaktionov for anti- 
CDK2 antiserum, Dr. F. Andrew Ray for providing HSF43 and 
CT10 cell lines, and Drs. Steve Friend and Michael Tainsky for 
providing Li-Fraumeni fibroblast cell lines. We thank Nancy 
Walworth and Konstantin Galaktionov for critical reading of 
the manuscript. We also thank Jim Duffy, Phil Renna, and Mike 
Ockler for artistic assistance. This work was supported by Na- 
tional Institutes of Health grant GM 425500 to D.B.D.B. is an 
Investigator of the Howard Hughes Medical Institute. 
The publication costs of this article were defrayed in part by 
payment of page charges. This article must therefore be hereby 
marked "advertisement" in accordance with 18 USC section 
1734 solely to indicate this fact. 
References 
Baldin, V., J. Lukas, M.J. Marcote, M. Pagano, and G. Draetta. 
1993. Cyclin D1 is a nuclear protein required for cell cycle 
progression i  G1. Genes & Dev. 7: 812-821. 
Bischoff, F.Z., S.O. Yim, S. Pathak, G. Grant, M.J. Siciliano, B.C. 
Giovanella, L.C Strong, and M.A. Tainsky. 1990. Spontane- 
ous abnormalities in normal fibroblasts from patients with 
Li-Fraumeni cancer syndrome: Aneuploidy and immortal- 
ization. Cancer Res. 50: 7979-7984. 
Booher, R. and D. Beach. 1988. Involvement of cdc13 + in mi- 
totic control in Schizosaccharomyces pombe: Possible inter- 
GENES & DEVELOPMENT 1581 
 Cold Spring Harbor Laboratory Press on November 3, 2017 - Published by genesdev.cshlp.orgDownloaded from 
Xiong et al. 
action of the gene product with microtubules. EMBO J. 
7: 2321-2327. 
Brizuela, L., G. Draetta, and D. Beach. 1987. p13 sur acts in the 
fission yeast cell division cycle as a component ofp34 cdc2 
protein kinase. EMBO J. 6: 3507-3514. 
Buchkovich, K., L.A. Duffy, and E. Harlow. 1989. The retino- 
blastoma protein is phosphorylated during specific phases of 
the cell cycle. Cell 58:1097-1105. 
Bueno, A., H. Richardson, ST Reed, and P. Russell. 1991. A 
fission yeast B-type cyclin functioning early in the cell cycle. 
Cell 66: 149-159. 
Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. 
Dyson. 1992. Independent binding of the retinoblastoma 
protein and p107 to the transcription factor E2F. Nature 
355: 176-179. 
Cleveland, D.W., S.G. Fisher, M.W. Kirschner, and U.K. Laem- 
mli. 1977. Peptide mapping by limited proteolysis n sodium 
dodecyl-sulfate and analysis by gel electrofocusing. J. Biol. 
Chem. 252:1102-1106. 
DeCaprio, J.A., J.W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, 
H. Piwnica-Worms, C.-M. Huang, and D.M. Livingston. 
1989. The product of retinoblastoma susceptibility gene has 
proterties of a cell cycle regulatory element. Cell 58: 1085- 
1095. 
Devoto, S.H., M. Mudryi, J. Pines, T. Hunter, and J.R. Nevins. 
1992. A cyclin A-protein kinase complex possesses e- 
quence-specific DNA binding activity: p33 oak2 is a compo- 
nent of the E2F-cyclin A complex. Cell 68: 167-176. 
Draetta, G. 1990. Cell cycle control in eukaryotes: Molecular 
mechanisms of cdc2 activation. Trends. Biol. Sci. 15: 378- 
383. 
Draetta, G. and D. Beach. 1988. Activation of cdc2 protein ki- 
nase during mitosis in human cells: Cell cycle-dependent 
phosphorylation a d subunit rearrangement. Cell 54:17-26. 
Draetta, G., L. Brizula, J. Potashkin, and D. Beach. 1987. Iden- 
tification of p34 and p13, human homolog of the cell cycle 
regulators of fission yeast encoded by cdc2 + and sucl +. Cell 
50:319-325.  
Draetta, G., F. Luca, J. Westendorf, L. Brizuela, J. Ruderman, and 
D. Beach. 1989. cdc2 protein kinase is complexed with both 
cyclin A and B: Evidence for proteolytic nactivation ofMPF. 
Cell 56: 829-838. 
Ducommun, B., P. Beambilla, M.A. Felix, B.R. Franza, E. 
Karsenti, and G. Draetta. 1991. cdc2 phosphorylation is re- 
quired for its interaction with cyclin. EMBO J. 10: 3311- 
3319. 
Elledge, S.J., R. Richman, F.L. Hall, R.T. Williams, N. Lodgson, 
and J.W. Harper. 1992. CDK2 encodes a33-kDa cyclin A-as- 
sociated protein kinase and is expressed before CDC2 in the 
cell cycle. Proc. Natl. Acad. Sci. 89: 2907-2911. 
Evans, T., E.T. Rosenthal, J. Youngblom, D. Distel, and T. Hunt. 
1983. Cyclin: A protein specified by maternal mRNA in sea 
urchin eggs that is destroyed at each cleavage division. Cell 
33: 389-396. 
Ewen, M.E., B. Faha, E. Harlow, and D.M. Livingston. 1992. 
Interaction of p107 with cyclin A independent of complex 
formation with viral oncoprotein. Science 255: 85-87. 
Faha, B., M.E. Ewen, L.-H. Tsai, D.M. Livingston, and E. Har- 
low. 1992. Interaction between human cyclin A and adeno- 
virus E1A-associated p107 protein. Science 255: 87-90. 
Fang, F. and J.W. Newport. 1991. Evidence that the G1-S and 
G2-M transitions are controlled by different cdc2 proteins in 
higher eukaryotes. Cell 66: 731-742. 
Ghiara, J.B., H.E. Richardson, K. Sugimoto, M. Henze, D.J. Lew, 
C. Witternberg, and S.I. Reed. 1991. A cyclin B homolog in S. 
cerevisiae: Chronic activation of the cdc28 protein kinase by 
cyclin prevents exit from mitosis. Cell 65: 163-174. 
Giordano, A., P. Whyte, E. Harlow, B.R. Franza, D. Beach, and 
G. Draetta. 1989. A 60 kD cdc2-associated polypeptide com- 
plexes with the E1A proteins in adenovirus-infected cells. 
Cell 58:981-990. 
Giordano, A., C. McCall, P. Whyte, and B.R. Franza. 1991. Hu- 
man cyclin A and retinoblastoma protein interact with sim- 
ilar but distinguishable s quences in the adenovirus E1A 
gene product. Oncogene 6:481--486. 
Gluzman, Y. 1981. SV40-transformed simian cells support he 
replication of early SV40 mutants. Cell 23: 175-182. 
Hall, F.L., R.K. Braun, K. Mihara, Y.T. Fung, N. Berndt, D.A. 
Carbonaro-Hall, and P.R. Vulliet. 1991. Characterization f 
the cytoplasmic proline-directed protein kinase in prolifera- 
tive cells and tissues as a heterodimer comprised of p34 cdr 
and p58 cyclinA. J. Biol. Chem. 266: 17430--17440. 
Hall, F.L., R.T. Williams, L. Wu, F. Wu, D.A. Carbonaro-Hall, 
J.W. Harper, and D. Warburton. 1993. Two potentially on- 
cogenic yclins, cyclin A and cyclin D 1, share common prop- 
erties of subunit configuration, tyrosine phosphorylation, 
and physical association with the Rb protein. Oncogene 
8: 1377-1384. 
Harlow, E. and D. Lane. 1988. Antibodies: A laboratory man- 
ual. Cold Spring Harbor Laboratory, Cold Spring Harbor, 
New York. 
Hunter, T. and J. Pines. 1991. Cyclins and cancer. Cell 
66" 1071-1074. 
Inaba, T., H. Matsushime, M. Valentine, M.F. Roussel, C.J. 
Sherr, and A.T. Look. 1992. Genomic organization, chromo- 
somal localization, and independent expression of human 
cyclin D genes. Genomics 13: 565-574. 
Kato, J-y., H. Matsushime, S.W. Hiebert, M. Ewen, C.J. Sherr. 
1993. Direct binding of cyclin D to the retinoblastoma gene 
product (pRb) and pRb phosphorylation by the cyclinD-de- 
pendent kinase CDK4. Genes & Dev. 7: 331-342. 
Lammie, G.A. and G. Peters. 1991. Chromosome llq13 abnor- 
malities in human cancer. Cancer Cells 3: 413--420. 
Lees, E., B. Faha, V. Dulic, S.I. Reed, and E. Harlow. 1992. Cyclin 
E/cdk2 and cyclin A: cdk2 kinases associate with p107 and 
E2F in a temporally distinct manner. Genes & Dev. 6: 1874- 
1885. 
Lew, D., V. Dulic, and S.I. Reed. 1991. Isolation of three novel 
human cyclins by rescue of G 1 cyclin (Cln) function in yeast. 
Cell 66:1197-1206. 
Li, F.P. and J.F. Fraumeni, Jr. 1969. Rhabdomyosarcoma in chil- 
dren: Epidemiology and identification of a familial cancer 
syndrome. J. Natl. Cancer Inst. 43: 1365-1373. 
Little, J.B., J. Nove, W.K. Dahlberg, P. Troilo, W.W. Nichols, and 
L.C. Strong. 1987. Normal cytoxic response of skin fibro- 
blasts from patients with Li-Fraumeni cancer sydrome to 
DNA-damaging agents in vitro. Cancer Res. 47: 4229-4234. 
Ludlow, J., J. Shon, D.M. Livingston, and J.A. DeCaprio. 1990. 
The retinoblastoma susceptibility gene product undergoes 
cell cycle-dependent dephosphorylation and binding to and 
release from SV40 T antigen. Cell 58: 1085-1095. 
Malkinn D., F. Li, L.C. Strong, J.F. Fraumeni, C.E. Nelson, D.H. 
Kim, G. Gryka, F.Z. Bischoff, M.A. Tainskym, and S.H. 
Friend. 1990. Germ line p53 mutation in a familial syndrome 
of sarcomas, breast cancer and other neoplasms. Science 
250: 1233-1238. 
Matsushime, H., M.F. Roussel, R.A. Ashmum, and C.J. Sherr. 
1991. Colony-stimulating factor 1 regulates a novel gene 
(CYL1) during the G1 phase of the cell cycle. Cell 65: 701- 
713. 
Matsushime, H., M.E. Ewen, D.K. Strom, J.-Y. Kato, S. Hanks, 
M.F. Roussel, and C.J. Sherr. 1992. Identification and prop- 
1582 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on November 3, 2017 - Published by genesdev.cshlp.orgDownloaded from 
Cell cycle and cellular transformation 
erties of an atypical catalytic subunit (p34pskq3/cdk4) for 
mammalian D-type G1 cyclins. Cell 71: 323-334. 
McCormick, J.J. and V.M. Maher. 1988. Towards an understand- 
ing of the malignant transformation f diploid human fibro- 
blasts. Mutat. Res. 199: 273-291. 
Meyerson, M., G.H. Enders, C.-L. Wu, L.-K. Su, C. Gorka, C. 
Neilson, E. Harlow, and L.-H. Tsai. 1992. A family of human 
cdc2-related protein kinases. EMB O ]. 11: 2909-2917. 
Motokura, T., T. Bloom, H.G. Kim, H. Juppner, J.V. Ruderman, 
H.M. Kronenberg, and A. Arnold. 1991. A BCLl-linked can- 
didate oncogene which is rearranged in parathyroid tumors 
encodes a novel cyclin. Nature 350: 512-515. 
Nevins, J. R. 1992. E2F: A link between the Rb tumor suppres- 
sor protein and viral oncoproteins. Science 258: 424-429. 
Okuda, T., J.L. Cleveland, and J.R. Downing. 1992. PCTAIRE-1 
and PCTAIRE-3, two members of a novel cdc2/CDC28-re- 
lated protein kinase gene family. Oncogene 7: 2249-2258. 
Pagano, M., G. Draetta, and P. Jansen-Durr. 1992a. Association 
of cdk2 kinase with the transcription factor E2F during S 
phase. Science 255:1144--1147. 
Pagano, M., R. Pepperkok, F.Verde, W. Ansorge, and G. Draetta. 
1992b. Cyclin A is required at two points in the human cell 
cycle. EMBO J. 11: 961-971. 
Paris, J., R.L. Guellec, A. Couturier, K.L. Guellec, F. Omilli, J. 
Camonis, S. MacNeill, M. Philippe. 1991. Cloning by differ- 
ential screening of a Xenopus cDNA coding for a protein 
highly homologous to cdc2. Proc. Natl. Acad. Sci. 88: 1039- 
1043. 
Pines, J. and T. Hunter. 1989. Isolation of a human cyclin 
cDNA: Evidence for cyclin mRNA and protein regulation i  
the cell cycle and for interaction with p34 cace. Cell 58: 833- 
846. 
9 1990. Human Cyclin A is adenovirus E1A- associated 
protein p60 and behaves differently from cyclin B. Nature 
346: 760-763. 
Prelich, G. and B. Stillman. 1988. Coordinated leading and lag- 
ging strand synthesis during SV40 DNA replication in vitro 
requires PCNA. Cell 53:117-126. 
Prelich, G., M. Kostura, D.R. Marshak, M.B. Mathews, and B. 
Stillman. 1987a. The cell cycle-regulated proliferating cell 
nuclear antigen is required for SV40 DNA replication in 
vitro. Nature 326: 471--475. 
Prelich, G., C.-K. Tan, M. Kostura, M.B. Mathews, A.G. So, 
K.M. Downey, and B.Stillman. 1987b. Functional identity of 
proliferating cell nuclear antigen and a DNA polymerase-8 
auxiliary protein Nature 326:517-520. 
Ray, F.A., D.S. Peabody, J.L. Cooper, L.S. Cram, and P.M. Krae- 
mer. 1990. SV40 T antigen alone drives karyotype instability 
that precedes neoplastic transformation of human diploid 
fibroblasts. J. Cell Biochem. 42: 13-31. 
Richardson, H.E., C.S. Stueland, J. Thomas, P. Russell, and ST 
Reed. 1990. Human cDNA encoding homologs of the small 
p34r162162 protein of Saccharomyces cerevisiae 
and Schizosaccharomyces pombe. Genes & Dev. 4: 1332-- 
1344. 
Rosenblatt, J., Y. Gu, and D.O. Morgan9 1992. Human cyclin- 
dependent kinase 2 is activated uring the S phase and G2 
phase of the cell cycle and associated with cyclin A. Proc. 
Natl. Acad. Sci. 89: 2824-2828. 
Rosenthal, E.T., T. Hunt, and J.V. Ruderman. 1980. Selective 
translation ofmRNA controls the pattern of protein synthe- 
sis during early development of the surf clam, Spisula so- 
lidissima. Cell 20: 487-494. 
Shay, J.W., W.E. Wright, and H. Werbin. 1991. Defining the 
molecular mechanisms ofhuman cell immortalization. Bio- 
chim. Biophys. Acta 1072: 1-7. 
Shay, J.W., M.D. West, and W.E. Wright. 1992. Re-expression f 
senescent markers in deinduced reversibly immortalized 
cells. Exp. Gerontol. 27: 477--492. 
Shiviji, M.K.K., M.K. Kenny, and R.D. Wood. 1992. Proliferating 
cell nuclear antigen is required for DNA excision repair. Cell 
69: 367-374. 
Shirodkar, S., M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Living- 
ston, and T. Chittenden. 1992. The transcription factor E2F 
interacts with the retinoblastoma product and a pl07-cyclin 
A complex in a cell cycle-regulated manner. Cell 68: 157- 
166. 
Srivastava, S., Z. Zou, K. Pirollo, W. Blattner, and E.H. Chang. 
1990. Germ-line transmission of a mutated p53 gene in a 
cancer-prone family with Li-Fraumeni syndrome. Nature 
348" 747-749. 
Surana, U., H. Robitsch, C. Price, T. Schuster, I. Fitch, A.B. 
Futcher, and K. Nasmyth. 1991. The role of CDC28 and 
cyclins during mitosis in the budding yeast S. cerevisiae. 
Cell 65: 145-161. 
Swenson, K.I., K.M. Farrell, and J.V. Ruderman. 1986. The clam 
embryo protein cyclin A induces entry into M phase and the 
resumption of meiosis in Xenopus oocytes. Cell 47: 867- 
870. 
Toschi, L. and R. Bravo9 1988. Changes in cyclin/proliferating 
cell nuclear antigen distribution during DNA repair synthe- 
sis. I. Cell Biol. 107: 1623-1628. 
Tsai, L.-H., E. Harlow, and M. Meyerson. 1991. Isolation of the 
human cdk2 gene that encodes the cyclin A-and adenovirus 
E 1A-associated p33 kinase. Nature 353:174--177. 
Wang, J., X. Chenivesse, B. Henglein, and C. Brechot. 1990. 
Hepatitis B virus integration i a cyclin A gene in a hepato- 
cellular carcinoma. Nature 343: 555-557. 
Wang, J., F. Zindy, X. Chenivesse, E. Lamas, B. Henglein, and C. 
Brechot. 1992. Modification of cyclin A expression by hep- 
atitis B virus DNA integration in a hepatocellular carci- 
noma. Oncogene 7: 1653-1656. 
Withers, D.A., R.C. Harvey, J.B. Faust, O. Melnyk, K. Carey, and 
T.C. Meeker. 1991. Characterization f a candidate bcl-1 
gene. Mol. Cell. Biol. 11: 4846--4853. 
Wittenberg, C., K. Sugimoto, and ST Reed. 1990. Gl-specific 
cyclin of S. cerevisiae; cell cycle periodicity, regulation by 
mating phermone, and association with p34 cdc28 protein 
kinase. Cell 62: 225-237. 
Xiong, Y. and D. Beach. 1991. Population exploration in the 
cyclin family. Curr. Biology 1: 362-364. 
Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human 
D-type cyclin. Cell 65: 691-699. 
Xiong, Y., J. Menninger, D. Beach, and D.C. Ward. 1992a. Mo- 
lecular cloning and chromosomal mapping of CCND genes 
encoding human D-type cyclins. Genomics 13: 575-584. 
Xiong, Y., H. Zhang, and D. Beach. 1992b. D-type cyclins asso- 
ciated with multiple protein kinases and the DNA replica- 
tion and repair factor PCNA. Cell 71: 505-514. 
Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. 
Wahl. 1992. Wild-type p53 restore cell cycle control and in- 
hibits gene amplification i  cells with mutant p53 alleles. 
Cell 70: 937-948. 
GENES & DEVELOPMENT 1583 
 Cold Spring Harbor Laboratory Press on November 3, 2017 - Published by genesdev.cshlp.orgDownloaded from 
 10.1101/gad.7.8.1572Access the most recent version at doi:
 7:1993, Genes Dev. 
  
Y Xiong, H Zhang and D Beach
  
with cellular transformation.











 click here.right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the top
Copyright © Cold Spring Harbor Laboratory Press
 Cold Spring Harbor Laboratory Press on November 3, 2017 - Published by genesdev.cshlp.orgDownloaded from 
